Lee's Pharmaceutical Holdings Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was HKD 387.02 million compared to HKD 368.34 million a year ago. Net income was HKD 34.22 million compared to HKD 13.84 million a year ago. Basic earnings per share from continuing operations was HKD 0.0581 compared to HKD 0.0235 a year ago. Diluted earnings per share from continuing operations was HKD 0.0581 compared to HKD 0.0235 a year ago.
For the nine months, sales was HKD 1,036.18 million compared to HKD 952.39 million a year ago. Net income was HKD 62.68 million compared to HKD 2,169.04 million a year ago. Basic earnings per share from continuing operations was HKD 0.1065 compared to HKD 3.6852 a year ago. Diluted earnings per share from continuing operations was HKD 0.1065 compared to HKD 3.6834 a year ago.